Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,218 | 988 | 99.0% |
| Education | $152.70 | 5 | 0.9% |
| Gift | $18.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $2,202 | 80 | $0 (2024) |
| ABBVIE INC. | $1,749 | 104 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,429 | 58 | $0 (2024) |
| PFIZER INC. | $1,386 | 133 | $0 (2024) |
| Novo Nordisk Inc | $1,176 | 71 | $0 (2024) |
| Allergan, Inc. | $964.17 | 65 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $543.99 | 29 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $529.02 | 33 | $0 (2022) |
| GlaxoSmithKline, LLC. | $515.87 | 28 | $0 (2024) |
| Lilly USA, LLC | $490.22 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,259 | 117 | AstraZeneca Pharmaceuticals LP ($297.60) |
| 2023 | $2,097 | 100 | AbbVie Inc. ($346.42) |
| 2022 | $2,319 | 126 | ABBVIE INC. ($467.77) |
| 2021 | $2,471 | 151 | AbbVie Inc. ($410.44) |
| 2020 | $1,739 | 108 | Amgen Inc. ($332.00) |
| 2019 | $1,940 | 117 | Novo Nordisk Inc ($335.81) |
| 2018 | $2,322 | 141 | Amgen Inc. ($586.97) |
| 2017 | $2,241 | 134 | AstraZeneca Pharmaceuticals LP ($353.97) |
All Payment Transactions
994 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $30.82 | General |
| Category: Automated insulin delivery system | ||||||
| 12/19/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Bone Health | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: Inflammation | ||||||
| 12/06/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| Category: Cardiovascular | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.66 | General |
| 12/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $33.02 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/14/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.52 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: VACCINE | ||||||
| 11/07/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $9.67 | General |
| 11/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Cardio-renal | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.60 | General |
| 10/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Biological | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,212 | 2,586 | $364,491 | $172,305 |
| 2022 | 23 | 2,487 | 2,953 | $375,383 | $94,586 |
| 2021 | 29 | 2,496 | 3,054 | $331,822 | $174,963 |
| 2020 | 32 | 2,827 | 3,587 | $357,475 | $173,872 |
All Medicare Procedures & Services
109 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 338 | 573 | $118,785 | $51,025 | 43.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 272 | 272 | $60,027 | $35,368 | 58.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 243 | 328 | $48,047 | $19,152 | 39.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 133 | 134 | $16,080 | $9,567 | 59.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 53 | 66 | $19,195 | $8,735 | 45.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 51 | 51 | $20,145 | $7,487 | 37.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 28 | 28 | $8,060 | $4,634 | 57.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 136 | 137 | $6,850 | $4,252 | 62.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 19 | 19 | $8,740 | $4,178 | 47.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 214 | 214 | $6,380 | $4,030 | 63.2% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 206 | 206 | $6,170 | $3,879 | 62.9% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2023 | 16 | 16 | $5,760 | $3,860 | 67.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 276 | 283 | $12,735 | $2,962 | 23.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 16 | $5,440 | $2,598 | 47.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 16 | 16 | $5,344 | $2,372 | 44.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $3,630 | $2,156 | 59.4% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 16 | 16 | $3,680 | $1,962 | 53.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 36 | 36 | $1,800 | $1,117 | 62.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 16 | 16 | $1,888 | $806.54 | 42.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 20 | $1,850 | $730.08 | 39.5% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 21 | 22 | $1,738 | $613.61 | 35.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 12 | 15 | $885.00 | $329.55 | 37.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 32 | $736.00 | $297.70 | 40.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 32 | 34 | $204.00 | $115.94 | 56.8% |
| G0404 | Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination | Office | 2023 | 23 | 23 | $322.00 | $77.38 | 24.0% |
About Dr. Celinde Strohl, MD
Dr. Celinde Strohl, MD is a Internal Medicine healthcare provider based in Littleton, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1912990409.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Celinde Strohl, MD has received a total of $17,389 in payments from pharmaceutical and medical device companies, with $2,259 received in 2024. These payments were reported across 994 transactions from 85 companies. The most common payment nature is "Food and Beverage" ($17,218).
As a Medicare-enrolled provider, Strohl has provided services to 10,022 Medicare beneficiaries, totaling 12,180 services with total Medicare billing of $615,726. Data is available for 4 years (2020–2023), covering 109 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Littleton, CO
- Active Since 08/30/2005
- Last Updated 11/23/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1912990409
Products in Payments
- UBRELVY (Drug) $799.41
- VRAYLAR (Drug) $753.58
- Aimovig (Biological) $673.96
- ENTRESTO (Drug) $513.68
- XARELTO (Drug) $482.34
- ELIQUIS (Drug) $468.64
- Repatha (Biological) $442.06
- NURTEC ODT (Drug) $402.90
- EVENITY (Biological) $371.12
- Ozempic (Drug) $361.05
- FARXIGA (Drug) $351.39
- BREZTRI (Drug) $323.75
- Dayvigo (Drug) $306.78
- Otezla (Drug) $303.09
- QULIPTA (Drug) $293.74
- Vascepa (Drug) $291.34
- Prolia (Biological) $275.48
- Saxenda (Drug) $263.60
- TRELEGY ELLIPTA (Drug) $261.19
- SYNTHROID (Drug) $252.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Littleton
Dr. Manojkumar Bupathi, M.d, M.D
Internal Medicine — Payments: $350,668
Grant Bailey, M.d, M.D
Internal Medicine — Payments: $94,777
Dr. Joshua Portnoy, M.d, M.D
Internal Medicine — Payments: $38,564
Dr. Sophia Ambruso, D.o, D.O
Internal Medicine — Payments: $37,607
Dr. Erin Riggle, M.d, M.D
Internal Medicine — Payments: $24,991
Kelly Greene, M.d, M.D
Internal Medicine — Payments: $16,955